Abstract
Objective:
To report a case of small cell carcinoma of the bladder. To analyse Literature data concerning disease stage, treatment and prognosis of small cell carcinoma of the bladder.
Methods/results:
We report a case of small cell carcinoma of the bladder with hepatic and skeletal metastases who underwent radical cystectomy and systemic chemotherapy. The patient died 9 months after surgery because of chemotherapy complications and in disease progression. The Authors reviewed and analysed Literature data concerning 139 cases of bladder small cell carcinoma with available follow-up.
Conclusions:
The extreme variability of treatment options, the small number of cases and stratification by stages make it very difficult to deduce therapeutic recommendations. The management that seems to give a better survival is the combination of radical cystectomy (or radiotherapy) and chemotherapy.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bone Neoplasms / secondary
-
Carboplatin / administration & dosage
-
Carboplatin / adverse effects
-
Carcinoma, Small Cell / drug therapy
-
Carcinoma, Small Cell / mortality
-
Carcinoma, Small Cell / pathology*
-
Carcinoma, Small Cell / secondary
-
Carcinoma, Small Cell / surgery
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects
-
Combined Modality Therapy
-
Cystectomy
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Etoposide / administration & dosage
-
Etoposide / adverse effects
-
Fatal Outcome
-
Humans
-
Ifosfamide / administration & dosage
-
Ifosfamide / adverse effects
-
Life Tables
-
Liver Neoplasms / secondary
-
Male
-
Middle Aged
-
Stevens-Johnson Syndrome / etiology
-
Survival Analysis
-
Urinary Bladder Neoplasms / drug therapy
-
Urinary Bladder Neoplasms / mortality
-
Urinary Bladder Neoplasms / pathology*
-
Urinary Bladder Neoplasms / surgery
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Carboplatin
-
Cisplatin
-
Ifosfamide